Efficacy and tolerability of EPs 7630 in patients (aged 6–18 years old) with acute bronchitis

@inproceedings{Kamin2010EfficacyAT,
  title={Efficacy and tolerability of EPs 7630 in patients (aged 6–18 years old) with acute bronchitis},
  author={Wolfgang Kamin and V Maydannik and F A Malek and Meinhard Kieser},
  booktitle={Acta paediatrica},
  year={2010}
}
AIM For EPs-7630, a herbal drug preparation from Pelargonium sidoides roots, therapeutic effects in respiratory tract infections outside the strict indication for antibiotics have already been demonstrated in adults. Now, a dose-finding study for EPs-7630 was performed in children and adolescents. METHODS A total of 400 patients (aged 6-18 years) were randomized to receive either 30 mg, 60 mg or 90 mg EPs-7630 or placebo daily. Primary outcome criterion was the change in the Bronchitis… CONTINUE READING